246 related articles for article (PubMed ID: 7736384)
1. p53 expression in patients with cirrhosis with and without hepatocellular carcinoma.
Livni N; Eid A; Ilan Y; Rivkind A; Rosenmann E; Blendis LM; Shouval D; Galun E
Cancer; 1995 May; 75(10):2420-6. PubMed ID: 7736384
[TBL] [Abstract][Full Text] [Related]
2. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
[TBL] [Abstract][Full Text] [Related]
3. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
[TBL] [Abstract][Full Text] [Related]
4. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
5. Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt.
Hussein MR
Liver Int; 2004 Dec; 24(6):552-60. PubMed ID: 15566504
[TBL] [Abstract][Full Text] [Related]
6. Mutation of p53 gene in regenerative nodules in cirrhotic liver.
Minouchi K; Kaneko S; Kobayashi K
J Hepatol; 2002 Aug; 37(2):231-9. PubMed ID: 12127428
[TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
Shieh YS; Nguyen C; Vocal MV; Chu HW
Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
[TBL] [Abstract][Full Text] [Related]
8. Loss of the tumor suppressor p53 gene at the liver cirrhosis stage in Japanese patients with hepatocellular carcinoma.
Kishimoto Y; Shiota G; Kamisaki Y; Wada K; Nakamoto K; Yamawaki M; Kotani M; Itoh T; Kawasaki H
Oncology; 1997; 54(4):304-10. PubMed ID: 9216855
[TBL] [Abstract][Full Text] [Related]
9. Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people.
Ng IO; Srivastava G; Chung LP; Tsang SW; Ng MM
Cancer; 1994 Jul; 74(1):30-7. PubMed ID: 8004579
[TBL] [Abstract][Full Text] [Related]
10. Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis.
Villar S; Ortiz-Cuaran S; Abedi-Ardekani B; Gouas D; Nogueira da Costa A; Plymoth A; Khuhaprema T; Kalalak A; Sangrajrang S; Friesen MD; Groopman JD; Hainaut P
PLoS One; 2012; 7(6):e37707. PubMed ID: 22675488
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma.
Goldblum JR; Bartos RE; Carr KA; Frank TS
Am J Surg Pathol; 1993 Dec; 17(12):1244-51. PubMed ID: 8238731
[TBL] [Abstract][Full Text] [Related]
12. Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma.
Ikeda A; Shimizu T; Matsumoto Y; Fujii Y; Eso Y; Inuzuka T; Mizuguchi A; Shimizu K; Hatano E; Uemoto S; Chiba T; Marusawa H
Gastroenterology; 2014 Jan; 146(1):222-32.e35. PubMed ID: 24055508
[TBL] [Abstract][Full Text] [Related]
13. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.
Volkmann M; Hofmann WJ; Müller M; Räth U; Otto G; Zentgraf H; Galle PR
Oncogene; 1994 Jan; 9(1):195-204. PubMed ID: 8302580
[TBL] [Abstract][Full Text] [Related]
14. Differential promoter usage for insulin-like growth factor-II gene in Chinese hepatocellular carcinoma with hepatitis B virus infection.
Tang SH; Yang DH; Huang W; Zhou M; Zhou HK; Lu XH; Ye G
Cancer Detect Prev; 2006; 30(2):192-203. PubMed ID: 16697535
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma.
Kishimoto Y; Shiota G; Wada K; Kitano M; Nakamoto K; Kamisaki Y; Suou T; Itoh T; Kawasaki H
J Cancer Res Clin Oncol; 1996; 122(10):585-9. PubMed ID: 8879255
[TBL] [Abstract][Full Text] [Related]
18. RB tumor suppressor gene expression in hepatocellular carcinomas from patients infected with the hepatitis B virus.
Hsia CC; Di Bisceglie AM; Kleiner DE; Farshid M; Tabor E
J Med Virol; 1994 Sep; 44(1):67-73. PubMed ID: 7798888
[TBL] [Abstract][Full Text] [Related]
19. DNA measurements in chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Lin HH; Shyu WC; Chen GL; Lin YH; Chen TJ; Liaw YF
Liver; 1990 Oct; 10(5):313-8. PubMed ID: 2175006
[TBL] [Abstract][Full Text] [Related]
20. The Differential Immunohistochemical Expression of p53, c-Jun, c-Myc, and p21 Between HCV-related Hepatocellular Carcinoma With and Without Cirrhosis.
Abdou AG; Abd-Elwahed M; Badr M; Helmy M; Soliman EA; Maher D
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):75-87. PubMed ID: 25710583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
